共 50 条
- [31] Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 390S - 399S
- [32] PROSTATE CANCER DETECTION WITH DIGITAL RECTAL EXAM IN THE PROSTATE LUNG COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL JOURNAL OF UROLOGY, 2016, 195 (04): : E548 - E549
- [34] Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 379S - 389S
- [35] Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial JOURNAL OF UROLOGY, 2023, 210 (04): : 630 - 637
- [36] FREE PSA AND CLINICALLY SIGNIFICANT ANDFATAL PROSTATE CANCER IN THE PLCO SCREENING TRIAL JOURNAL OF UROLOGY, 2023, 209 : E996 - E997
- [38] White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) BREAST CANCER RESEARCH, 2017, 19
- [39] The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort British Journal of Cancer, 2018, 118 : 299 - 306
- [40] Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort Cancer Causes & Control, 2011, 22 : 995 - 1002